LOS ANGELES, March 01, 2017 -- Ducommun Incorporated (NYSE:DCO) (“Ducommun” or the “Company”) today announced that it will participate in the 29th Annual Roth Capital Conference on Monday, March 13, 2017 in Dana Point, California. Management’s formal presentation is planned for 5:00 p.m. Pacific Time, and meetings with institutional investors will take place throughout the day.
Additional information will be posted on the Company’s website when available, including a live audio webcast. To hear the presentation and view related materials, please visit the website at www.ducommun.com. A replay will typically be available for ninety days.
About Ducommun Incorporated
Ducommun Incorporated delivers value-added, innovative manufacturing solutions to customers in the aerospace, defense and industrial markets. Founded in 1849, the company specializes in two core areas – Electronic Systems and Structural Systems – to produce complex products and components for commercial aircraft platforms, mission-critical military and space programs, and sophisticated industrial applications. For more information, visit www.ducommun.com.
CONTACTS: Douglas L. Groves, Vice President, Chief Financial Officer and Treasurer, 310.513.7200 Chris Witty, Investor Relations, 646.438.9385, [email protected]


Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 



